Sylvia Gutz

Leipzig, SN, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Prevention, Diagnosis, Therapy, and Follow-up of Lung Cancer - Interdisciplinary Guideline of the German Respiratory Society and the German Cancer Society - Abridged Version

Prevention, Diagnosis, Therapy, and Follow-up of Lung Cancer - Interdisciplinary Guideline of the German Respiratory Society and the German Cancer Society - Abridged Version

Journal: Pneumologie (Stuttgart, Germany)

Published: October 26, 2023

Incidental Pulmonary Nodules - What Do We Know in 2022.

Incidental Pulmonary Nodules - What Do We Know in 2022.

Journal: Respiration; international review of thoracic diseases

Published: May 25, 2022

Two-year survival with nivolumab in previously treated advanced non-small-cell lung cancer: A real-world pooled analysis of patients from France, Germany, and Canada.

Two-year survival with nivolumab in previously treated advanced non-small-cell lung cancer: A real-world pooled analysis of patients from France, Germany, and Canada.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: February 19, 2021

Prospective, Noninterventional Study of Nivolumab in Real-world Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Chemotherapy (ENLARGE-Lung).

Prospective, Noninterventional Study of Nivolumab in Real-world Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Chemotherapy (ENLARGE-Lung).

Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)

Published: December 07, 2020

Lorlatinib in pretreated ALK- or ROS1-positive lung cancer and impact of TP53 co-mutations: results from the German early access program.

Lorlatinib in pretreated ALK- or ROS1-positive lung cancer and impact of TP53 co-mutations: results from the German early access program.

Journal: Therapeutic advances in medical oncology

Published: September 15, 2020

Everolimus with paclitaxel and carboplatin as first-line treatment for metastatic large-cell neuroendocrine lung carcinoma: a multicenter phase II trial.

Everolimus with paclitaxel and carboplatin as first-line treatment for metastatic large-cell neuroendocrine lung carcinoma: a multicenter phase II trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: May 24, 2017

Metronomic treatment of advanced non-small-cell lung cancer with daily oral vinorelbine - a Phase I trial.

Metronomic treatment of advanced non-small-cell lung cancer with daily oral vinorelbine - a Phase I trial.

Journal: OncoTargets and therapy

Published: March 07, 2017

Title Not Found

Title Not Found

Journal: Pneumologie (Stuttgart, Germany)

Published: December 09, 2016

Title Not Found

Title Not Found

Journal: Pneumologie (Stuttgart, Germany)

Published: December 09, 2016

Fine needle aspiration of peripheral lymph nodes

Fine needle aspiration of peripheral lymph nodes

Journal: Deutsche medizinische Wochenschrift (1946)

Published: November 20, 2015

Experience with afatinib in patients with non-small cell lung cancer progressing after clinical benefit from gefitinib and erlotinib.

Experience with afatinib in patients with non-small cell lung cancer progressing after clinical benefit from gefitinib and erlotinib.

Journal: The oncologist

Published: September 19, 2014

Molecular pathological diagnosis in cytopathology of non-small-cell lung cancer. Standardization of specimen processing

Molecular pathological diagnosis in cytopathology of non-small-cell lung cancer. Standardization of specimen processing

Journal: Der Pathologe

Published: June 04, 2013

Showing 1-12 of 14

Last Updated: 09/26/2026